Rabbit Anti-Human Phospho-STAT5a(Y694) Antibody, 400 ul
Loading...
Loading...
Loading...
Loading...
| Size | 400 µL |
| Estimated Lead Time | 1-2 weeks |
| Species | Human |
| Host Species | Rabbit |
| Accession Number | P42229 |
| Gene Id | 6776 |
| Gene Symbols | STAT5A |
| Protein Name / Synonyms | Phospho-STAT5a(Y694) |
| Clonality | Polyclonal |
| Preparation | This STAT5a Antibody is generated from rabbits immunized with a KLH conjugated synthetic phosphopeptide corresponding to amino acid residues surrounding Y694 of human STAT5a. |
| Concentration (lot specific) | 0.400 mg/ml |
| Recommended Applications | Western Blotting, IHC-P, IF |
| Research Area | Inflammation |
| Shipping Type | Blue ice |
| Storage | -20°C |
![]() | Western blot analysis of anti-Phospho-STAT5 Pab(Cat# 102-15361) in HepG2 cell line lysate (35ug/lane). Phospho-STAT5(arrow) was detected using the purified Pab. |
![]() | Fluorescent confocal image of an SY5Y cell stained with 102-15361 Phospho-STAT5a antibody. SY5Y cells were fixed with 4% PFA (20 min), permeabilized with Triton X-100 (0.2%, 30 min), then incubated with 102-15361 Phospho-STAT5a primary antibody (1:200, 2 h at room temperature). For secondary antibody, Alexa Fluor® 488 conjugated donkey anti-rabbit antibody (green) was used (1:1000, 1h).Cytoplasmic actin was counterstained with Alexa Fluor® 555 (red) conjugated Phalloidin (5.25 µM, 25 min). Nuclei were counterstained with Hoechst 33342 (blue) (10 µg/ml, 3 min)(not shown). Phospho-STAT5a immunoreactivity is localized exclusively to the nucleus. |
![]() | Formalin-fixed and paraffin-embedded human cancer tissue reacted with the primary antibody, which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated. BC = breast carcinoma; HC = hepatocarcinoma. |
Anti-Phospho-STAT5a (Y694) Antibody
Anti-Phospho-STAT5a (Y694) Antibody
Sign up to get promotions on your favorite research tools and research updates.